Ye Y et al. – These results demonstrate that peripherally administered pharmacological agents targeting IB4 (+) neurons, such as a selective δ–opioid receptor agonist or P2X3 antagonist, might be useful in treating oral cancer pain. [more...]
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close